Pediatric Dose Individualization

Pediatric Dose Individualization is a clinical pharmacology strategy that tailors medication dosage regimens to individual pediatric patients based on developmental, physiological, and genetic factors to optimize therapeutic efficacy and minimize toxicity.

20

Publications

1.4K

Citations

106

Authors

63

Institutions

Publications per year

2017–2026

4

Authors

106

  1. MH
    Michael Højby Rasmussen

    Novo Nordisk (Denmark), Denmark

    2 publications · 99 citations

    2

    h-index

  2. JW
    JE Wagner

    Johns Hopkins University, United States

    2 publications · 164 citations

    2

    h-index

  3. AA
    Alexander A. Vinks

    Cincinnati Children's Hospital Medical Center, United States

    2 publications · 77 citations

    2

    h-index

  4. RJ
    RJ Jones

    Johns Hopkins University, United States

    2 publications · 164 citations

    2

    h-index

  5. TB
    Tadej Battelino

    Ljubljana University Medical Centre, Slovenia

    2 publications · 99 citations

    2

    h-index

1–5 of 106

Venues

  1. British Journal of Clinical Pharmacology

    BJCP · 3 publications · 158 citations

    3

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 2 publications · 32 citations

    2

    h-index

  3. Therapeutic Drug Monitoring

    2 publications · 58 citations

    2

    h-index

  4. Blood

    2 publications · 164 citations

    2

    h-index

  5. Bone Marrow Transplantation

    2 publications · 124 citations

    2

    h-index

1–5